THURSDAY, July 28, 2016 — Adlyxin (lixisenatide) has been approved by the U.S.Food and Drug Administration to treat type 2 diabetes in adults, the agency said Thursday in a news release. As the FDA explained, Adlyxin is a “glucagon-like peptide-1 receptor agonist” — a hormonal drug that helps control blood ... Read More »